Study Warns of Risks from Long-Term Use of Oral Corticosteroids for Atopic Dermatitis
A recent study in JAMA Network Open reveals that prolonged use of oral corticosteroids for atopic dermatitis can increase the risk of adverse events. Conducted by Dr. Yong Hyun Jang, the research analyzed over 164,000 cases and recommends limiting corticosteroid treatment to 90 days to mitigate potential risks. This study emphasizes the importance of careful treatment duration in managing atopic dermatitis and may influence future clinical guidelines.
Study on Multi-Organ Immune-Related Adverse Events from Immune Checkpoint Inhibitors
A recent multicohort study delves into the co-occurrence patterns and outcomes of multi-organ immune-related adverse events in patients receiving immune checkpoint inhibitors. Leveraging data from multiple renowned hospitals, the study sheds light on the impact of these adverse events and their implications on patient survival. By analyzing clusters of patients and conducting overall survival analyses, the researchers provide valuable insights for healthcare providers managing patients undergoing immunotherapy.